Over the trailing 12 months, OKUR insiders sold $5,630 worth of shares (1.55K shares) in open-market trades, with no open-market purchases.
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Bioventures, L.P. Acorn | TenPercentOwner | 1,709,944 | 1,129,730 | 2,839,674 | 72.6% | 19 May, 2025 |
| 2 | Braden Michael Leonard | Other | 102,076 | 345,739 | 447,815 | 11.4% | 09 Oct, 2024 |
| 3 | Holdings A/S Novo | TenPercentOwner | 333,034 | 0 | 333,034 | 8.5% | 23 Jun, 2023 |
| 4 | Niall O'Donnell | Director | 0 | 218,871 | 218,871 | 5.6% | 10 May, 2023 |
| 5 | Isaac Manke | Director | 20,583 | 0 | 20,583 | 0.5% | 02 Jan, 2026 |
| 6 | Jason A. Leverone | Chief Financial Officer | 18,500 | 0 | 18,500 | 0.5% | 23 Sep, 2026 |
| 7 | Edward T Mathers | Director | 15,310 | 0 | 15,310 | 0.4% | 02 Jan, 2026 |
| 8 | Nicholas A Saccomano | President And Ceo | 11,160 | 0 | 11,160 | 0.3% | 23 Sep, 2026 |
| 9 | Ashley Hall | Chief Development Officer | 3,960 | 0 | 3,960 | 0.1% | 29 Aug, 2023 |
| 10 | Alejandro Dorenbaum | Chief Medical Officer | 3,000 | 0 | 3,000 | 0.1% | 13 Dec, 2022 |
| 11 | Michael Cruse | Chief Operating Officer | 0 | 1,370 | 1,370 | 0.0% | 02 Sep, 2022 |
| 12 | R Michael Carruthers | Director | 494 | 0 | 494 | 0.0% | 08 Oct, 2024 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 21 Sep, 2026 | Jason A. Leverone | Chief Financial Officer | Disposed S | 302 | $2.97 | $898 | 18,500 | Direct |
| 21 Sep, 2026 | Nicholas A Saccomano | President And Ceo | Disposed S | 87 | $2.97 | $259 | 11,160 | Direct |
| 07 Aug, 2026 | Nicholas A Saccomano | President And Ceo | Acquired A | 150,000 | $0.00 | $0 | 150,000 | Direct |
| 07 Aug, 2026 | Jason A. Leverone | Chief Financial Officer | Acquired A | 50,000 | $0.00 | $0 | 50,000 | Direct |
| 07 Aug, 2026 | Valerie Malyvanh Jansen | Director | Acquired A | 22,350 | $0.00 | $0 | 22,350 | Direct |
| 07 Aug, 2026 | Edward T Mathers | Director | Acquired A | 22,350 | $0.00 | $0 | 22,350 | Direct |
| 07 Aug, 2026 | Michael G Grey | Director | Acquired A | 22,350 | $0.00 | $0 | 22,350 | Direct |
| 07 Aug, 2026 | Andrew John Phillips | Director | Acquired A | 22,350 | $0.00 | $0 | 22,350 | Direct |
| 07 Aug, 2026 | Dylan Hartley | Chief Scientific Officer | Acquired A | 50,000 | $0.00 | $0 | 50,000 | Direct |
| 07 Aug, 2026 | Liam Ratcliffe | Director | Acquired A | 22,350 | $0.00 | $0 | 22,350 | Direct |
| 07 Aug, 2026 | Isaac Manke | Director | Acquired A | 300,000 | $0.00 | $0 | 300,000 | Direct |
| 07 Aug, 2026 | Samuel Agresta | Chief Medical Officer | Acquired A | 50,000 | $0.00 | $0 | 50,000 | Direct |
| 07 Aug, 2026 | R Michael Carruthers | Director | Acquired A | 22,350 | $0.00 | $0 | 22,350 | Direct |
| 07 Aug, 2026 | Nicholas A Saccomano | President And Ceo | Disposed D | 2,359 | — | — | 0 | Direct |
| 07 Aug, 2026 | Dylan Hartley | Chief Scientific Officer | Disposed D | 137,603 | — | — | 0 | Direct |
| 07 Aug, 2026 | Samuel Agresta | Chief Medical Officer | Disposed D | 18,588 | — | — | 0 | Direct |
| 07 Aug, 2026 | Isaac Manke | Director | Disposed D | 15,300 | — | — | 0 | Direct |
| 07 Aug, 2026 | Jason A. Leverone | Chief Financial Officer | Disposed D | 5,781 | — | — | 0 | Direct |
| 07 Aug, 2026 | Nicholas A Saccomano | President And Ceo | Acquired A | 2,359 | — | — | 2,359 | Direct |
| 07 Aug, 2026 | Isaac Manke | Director | Acquired A | 15,300 | — | — | 15,300 | Direct |